Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Intra-Cellular Ther (ITCI)

Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Intra-Cellular Therapies Presents New Efficacy and Safety Data for CAPLYTA in Major Depressive Disorder at ACNP Annual Meeting Quiver Quantitative, Inc. - Wed Dec 11, 5:22PM CST

Intra-Cellular Therapies presents new data on CAPLYTA's efficacy and safety in treating major depressive disorder at ACNP conference.Quiver AI SummaryIntra-Cellular Therapies, Inc. presented new data on...

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting GlobeNewswire - Wed Dec 11, 7:00AM CST

ITCI : 83.45 (-0.82%)
Insider Sale: Chairman and CEO of $ITCI (ITCI) Sells 1,534 Shares Quiver Quantitative, Inc. - Sat Dec 7, 3:30AM CST

Sharon Mates, the Chairman and CEO of $ITCI ($ITCI), sold 1,534 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their...

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies Submits Supplemental New Drug Application for CAPLYTA as Adjunctive Therapy in Major Depressive Disorder Quiver Quantitative, Inc. - Tue Dec 3, 4:48PM CST

Intra-Cellular Therapies submitted an sNDA for CAPLYTA to treat Major Depressive Disorder, demonstrating efficacy and safety.Quiver AI SummaryIntra-Cellular Therapies, Inc. announced the submission of...

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy GlobeNewswire - Tue Dec 3, 6:30AM CST

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences GlobeNewswire - Tue Nov 19, 7:00AM CST

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies (NASDAQ: ITCI): A Comprehensive Analysis wealthyventurecapitalist.com - Tue Nov 12, 6:20PM CST

Company Overview Intra-Cellular Therapies (NASDAQ: ITCI) is a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders. The company’s primary product...

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies (NASDAQ: ITCI): A Comprehensive Analysis wealthyventurecapitalist.com - Tue Nov 12, 3:07PM CST

Company Overview Intra-Cellular Therapies (NASDAQ: ITCI) is a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders. The company’s primary product...

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress GlobeNewswire - Thu Nov 7, 7:00AM CST

ITCI : 83.45 (-0.82%)
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia GlobeNewswire - Tue Nov 5, 6:00AM CST

ITCI : 83.45 (-0.82%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot